GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

HALIFAX - Nova Scotia’s Progressive Conservatives say that if re-elected Nov. 26 they will introduce a universal shingles ...

Housing remained the focus of the NDP on Tuesday, as leader Claudia Chender promised to create a compliance and enforcement ...

The government’s deal with Maryland-based Novavax requires the company to obtain regulatory approval for a vaccine using ingredients made at the Biologics Manufacturing Centre (BMC) in Montreal before ...

Nova Scotia’s top party leaders are talking traffic congestion, seniors’ health and rental disputes as the provincial ...

But the situation is much different in Nova Scotia. "At this point, it doesn't seem like we're going to be getting this vaccine," said Hannah Markham. "At least [not] any time soon." Markham ...

Two more cases of measles have been confirmed in New Brunswick, bringing the total number of cases to five. On Oct. 24, New ...

This update in the health sector highlights major developments including DiaSorin's significant profit growth, GSK's RSV ...

The City of Windsor is suing the federal government over the costs incurred due to the so-called Freedom Convoy blockade.

Posting the video in which Trudeau was seen getting vaccine administrated, he wrote, "It’s that time of year. Take a couple ...

By Mark Gargarian Noubar and Anna Afeyan first met in 1986 at an American Chemical Society meeting in Anaheim, California.